Drug Approval | April 04, 2025
Gland Pharma receives approval for Acetaminophen Injection
The company expects to launch this product through its marketing partner in the near future
The company expects to launch this product through its marketing partner in the near future
The Peptide Research Center is designed to support innovator pharma and biotech companies with specialized services across peptide synthesis, discovery, and advanced modalities, including complex conjugates
Approval brings AstraZeneca and Daiichi Sankyo’s Enhertu earlier in the treatment of HR-positive, HER2-low breast cancer and broadens the eligible patient population to those with HER2-ultralow disease
Awards highlight Avantor's commitment to the Biopharma industry
The portfolio includes branded injectable cephalosporines for infectious diseases
The IND application supports the next phase of development of SBO-154
New trontinemab data continue to support rapid and deep, dose-dependent reduction of amyloid plaques in Phase Ib/IIa Brainshuttle AD study
Approval based on AEGEAN Phase III trial results which showed a 32% reduction in the risk of recurrence, progression or death vs. neoadjuvant chemotherapy alone
The company offers customized formulations tailored to align with each brand’s identity and consumer needs
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
